Status:
TERMINATED
Bronchoscopic Intratumoral Chemotherapy for Small Cell Lung Cancer (SCLC)
Lead Sponsor:
University of Florida
Conditions:
Small Cell Lung Cancer
Eligibility:
All Genders
Phase:
PHASE3
Brief Summary
This project proposes to use bronchoscopic intratumoral chemotherapy for small cell lung cancer in two fashions: 1. to implement a prospective clinical trial to test the feasibility and efficacy of i...
Detailed Description
Subjects will receive standard of care treatment for SCLC with added treatment of Cisplatin injection via endobronchial ultrasound aided bronchoscopy a total of four times. Outcome measurements of tum...
Eligibility Criteria
Inclusion
- Competent adult English speaking subjects
- With limited stage SCLC who have completed standard of care treatment who are responders with no evidence of disseminated disease other than CNS metastasis,
- With recurrent disseminated SCLC after standard of care treatment with symptoms related to central tumor obstruction,
- With recurrent limited stage SCLC with mediastinal/hilar recurrence not previously treated with intratumoral cisplatin
Exclusion
- Subjects who do not meet the inclusion criteria
- Subjects who, in the opinion of the investigator, are at risk undergoing a bronchoscopy
Key Trial Info
Start Date :
December 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2015
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT01487499
Start Date
December 1 2011
End Date
March 1 2015
Last Update
June 11 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Florida
Gainesville, Florida, United States, 32610